PROMOPHARM

Management

Chairman and CEO

ARAIDAH Ma’moun

Deputy Managing director

ALAOUI Amine

Financial Manager

EL BOUACHI Said

Main shareholders

08/09/2023

HIKMA MENA FZE94,12 %
DIVERS ACTIONNAIRES 5,88 %
HIKMA INVESTMENT LLC0,00 %
HIKMA PHARMACEUTICALS LLC0,00 %
ARAB MANUFACTURING COMPANY PLC0,00 %
DARWAZEH MAZEN0,00 %
ALARAIDEH MA''MON SALAMEH MUHAISEN0,00 %
Total100,00 %

Key indicators

Company information

Company name SOCIETE DE PROMOTION PHARMACEUTIQUE DU MAGHREB
Corporate address Rue 7. zone industrielle du Sahel. BP 96/97. 26 400. Had Soualem. Maroc
External auditorsMohammed Youssef SEBTI / PWC
Date of creation28/08/1947
Date of IPO15/06/2007
Length of fiscal year12
Social object
Production. marketing and sale. representation. import and export of all pharmaceutical specialties. OTC drugs and personal hygiene products in Morocco or overseas

Key figures (1)

2023

2022

2021

Consolidated accountsNoNoNo
Share capital100 000 000,00100 000 000,00100 000 000,00
Equity475 765 782,17458 867 835,35423 589 590,55
Number of titles(2)1 000 0001 000 0001 000 000
Sales figures805 516 174,90704 639 805,16630 491 043,46
Operating result100 662 043,33134 115 436,66104 922 804,49
Net income (4)56 897 946,8275 278 244,8068 970 135,27

At the end of the financial year.

All lines of action combined.

(3) Equity of the consolidated group for companies publishing consolidated accounts

Net income Group share for companies publishing consolidated accounts.

Ratio

Ratios202320222021
BPA56,9075,2868,97
ROE (in %)11,9616,4116,28
Payout (in %)-53,1458,00
Dividend yield (in %)-3,753,51
PER17,5814,1916,53
PBR2,102,332,69

Investor Relations - Contacts

Contacts

Said EL BOUACHI

Phone

+212 5 22 96 45 67 - 0661 878 518

Fax

+212 5 22 96 47 01

Corporate Website

www.promopharm.co.ma

Financial operation

Capital increase

Date

Capital after operation

Type of operation

Securities variation

Nominal value

Nominal value

Effective date

Fiscal period

EGM decision

Ratification authority

No results found

Dividend

Year

Dividend amount

Dividend type

Ex-date

Payment date

2022

40,00

Ordinary

11/09/2023

20/09/2023

2021

40,00

Ordinary

08/07/2022

20/07/2022

2020

30,00

Ordinary

12/07/2021

26/07/2021

2016

148,00

Ordinary

09/05/2017

18/05/2017

2015

169,00

Ordinary

20/05/2016

31/05/2016

2014

80,00

Ordinary

15/09/2015

28/09/2015

2013

75,00

Ordinary

17/07/2014

31/07/2014

2012

130,00

Ordinary

11/07/2013

22/07/2013

2011

45,00

Ordinary

18/07/2012

27/07/2012

Bond issue

Ticker

Name or title

Bond type

nominal value

Rate

Eligibility date

Maturity date

Type of amortization

Amount issued

Remaining Capital

No results found

Date

Declarant

Quantity

Price

Treshold crossed in %

Direction

Intention of the declarant

05/01/2012

RCAR

50 043

1 155,00

5,00

Decrease

-

29/11/2011

HIKMA MENA HOLDING LIMITED

56 361

1 154,79

66,66

Rise

Continu its purchases of the security

29/11/2011

RMA CAPITAL

30 000

1 155,00

5,00

Decrease

-

03/10/2011

CHAMI RACHIDA

80 935

1 155,00

5,00

Decrease

-

03/10/2011

MOUSSAHAMA

117 058

1 765,00

5,00

Decrease

-

03/10/2011

MERNISSI MOHAMMED KAMAL

121 448

1 765,00

5,00

Decrease

-

03/10/2011

Chiesi Farmaceutici

52 388

1 425,00

5,00

Decrease

-

03/10/2011

HIKMA MENA FZE

638 985

1 765,00

50,00

Rise

Continu its purchases of the security

02/08/2011

MERNISSI MOHAMMED KAMAL

21 512

762,00

10,00

Rise

-

16/08/2007

RCAR

2 072

903,46

5,00

Rise

-

The instruments of the issuer

Ticker

Instrument

PRO

PROMOPHARM S.A.

©2023 Casablanca Stock Exchange - All rights reserved

Made by VOID